(AMTX) Aemetis - Ratings and Ratios
Ethanol, Renewable Natural Gas, Biodiesel, Animal Feed, Glycerin
AMTX EPS (Earnings per Share)
AMTX Revenue
Description: AMTX Aemetis
Aemetis Inc (NASDAQ:AMTX) is a renewable energy company that specializes in producing low and negative carbon intensity products, operating through three main segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The companys diverse product portfolio includes ethanol, animal feed, biodiesel, renewable natural gas, and USP alcohol, catering to various industries such as transportation, dairy, and feedlots.
From a business perspective, Aemetis is well-positioned to capitalize on the growing demand for renewable energy sources. The companys focus on reducing carbon intensity aligns with increasing environmental regulations and consumer preferences. Key Performance Indicators (KPIs) to monitor Aemetis performance include revenue growth, gross margin expansion, and production capacity utilization. For instance, the companys ability to maintain a high capacity utilization rate in its ethanol and biodiesel production facilities will be crucial in driving profitability.
Analyzing Aemetis financials, the companys Return on Equity (RoE) of 40.02% indicates strong profitability. To further assess the companys financial health, other essential KPIs include Debt-to-Equity ratio, Interest Coverage ratio, and Cash Flow from Operations. Aemetis market capitalization of $169.43M USD suggests a relatively small-cap stock, which may be more susceptible to price volatility. As a Trading Analyst, its essential to closely monitor the companys financial performance, industry trends, and competitive landscape to identify potential trading opportunities.
From a growth perspective, Aemetis expansion into new markets, such as the production of renewable natural gas, and its presence in the Indian biodiesel market, could be key drivers of future growth. The companys ability to successfully execute its growth strategy, manage costs, and maintain a competitive edge will be critical in determining its long-term success. Monitoring KPIs such as revenue growth rate, new product development, and geographic expansion will be essential in assessing Aemetis progress.
AMTX Stock Overview
| Market Cap in USD | 154m |
| Sub-Industry | Oil & Gas Refining & Marketing |
| IPO / Inception | 2014-05-15 |
AMTX Stock Ratings
| Growth Rating | -58.5% |
| Fundamental | 20.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -24.3% |
| Analyst Rating | 4.0 of 5 |
AMTX Dividends
Currently no dividends paidAMTX Growth Ratios
| Growth Correlation 3m | -34.2% |
| Growth Correlation 12m | -29.9% |
| Growth Correlation 5y | -67.5% |
| CAGR 5y | -33.83% |
| CAGR/Max DD 3y | -0.40 |
| CAGR/Mean DD 3y | -0.56 |
| Sharpe Ratio 12m | -0.05 |
| Alpha | 0.40 |
| Beta | 0.000 |
| Volatility | 78.48% |
| Current Volume | 761k |
| Average Volume 20d | 547.7k |
| Stop Loss | 2 (-8.3%) |
| Signal | -1.19 |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-82.1m TTM) > 0 and > 6% of Revenue (6% = 13.4m TTM) |
| FCFTA -0.22 (>2.0%) and ΔFCFTA -13.84pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -135.0% (prev -34.81%; Δ -100.2pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.10 (>3.0%) and CFO -23.1m > Net Income -82.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (57.7m) change vs 12m ago 29.85% (target <= -2.0% for YES) |
| Gross Margin -2.95% (prev -0.38%; Δ -2.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.71% (prev 120.1%; Δ -25.35pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.13 (EBITDA TTM -42.9m / Interest Expense TTM 46.5m) >= 6 (WARN >= 3) |
Altman Z'' -19.26
| (A) -1.26 = (Total Current Assets 20.1m - Total Current Liabilities 321.9m) / Total Assets 240.0m |
| (B) -2.55 = Retained Earnings (Balance) -610.9m / Total Assets 240.0m |
| warn (B) unusual magnitude: -2.55 — check mapping/units |
| (C) -0.22 = EBIT TTM -52.4m / Avg Total Assets 236.1m |
| (D) -1.17 = Book Value of Equity -617.2m / Total Liabilities 529.3m |
| Total Rating: -19.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 20.41
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield -10.70% = -5.0 |
| 3. FCF Margin -23.79% = -7.50 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda -8.05 = -2.50 |
| 6. ROIC - WACC (= -88.68)% = -12.50 |
| 7. RoE data missing |
| 8. Rev. Trend 21.66% = 1.62 |
| 9. EPS Trend 5.77% = 0.29 |
What is the price of AMTX shares?
Over the past week, the price has changed by +1.40%, over one month by -11.38%, over three months by -3.54% and over the past year by -10.29%.
Is Aemetis a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AMTX is around 1.65 USD . This means that AMTX is currently overvalued and has a potential downside of -24.31%.
Is AMTX a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AMTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 519.3% |
| Analysts Target Price | 13.5 | 519.3% |
| ValueRay Target Price | 1.8 | -18.8% |
Last update: 2025-09-05 04:32
AMTX Fundamental Data Overview
CCE Cash And Equivalents = 1.65m USD (Cash And Short Term Investments, last quarter)
P/S = 0.6874
Beta = 1.345
Revenue TTM = 223.6m USD
EBIT TTM = -52.4m USD
EBITDA TTM = -42.9m USD
Long Term Debt = 73.6m USD (from longTermDebt, last quarter)
Short Term Debt = 271.4m USD (from shortTermDebt, last quarter)
Debt = 345.0m USD (Calculated: Short Term 271.4m + Long Term 73.6m)
Net Debt = 476.9m USD (from netDebt column, last quarter)
Enterprise Value = 497.1m USD (153.7m + Debt 345.0m - CCE 1.65m)
Interest Coverage Ratio = -1.13 (Ebit TTM -52.4m / Interest Expense TTM 46.5m)
FCF Yield = -10.70% (FCF TTM -53.2m / Enterprise Value 497.1m)
FCF Margin = -23.79% (FCF TTM -53.2m / Revenue TTM 223.6m)
Net Margin = -36.70% (Net Income TTM -82.1m / Revenue TTM 223.6m)
Gross Margin = -2.95% ((Revenue TTM 223.6m - Cost of Revenue TTM 230.2m) / Revenue TTM)
Tobins Q-Ratio = -0.81 (set to none) (Enterprise Value 497.1m / Book Value Of Equity -617.2m)
Interest Expense / Debt = 4.16% (Interest Expense 14.4m / Debt 345.0m)
Taxrate = 21.0% (US default)
NOPAT = -52.4m (EBIT -52.4m, no tax applied on loss)
Current Ratio = 0.06 (Total Current Assets 20.1m / Total Current Liabilities 321.9m)
Debt / EBITDA = -8.05 (Net Debt 476.9m / EBITDA -42.9m)
Debt / FCF = -6.49 (Debt 345.0m / FCF TTM -53.2m)
Total Stockholder Equity = -273.2m (last 4 quarters mean)
RoA = -34.19% (Net Income -82.1m, Total Assets 240.0m )
RoE = unknown (Net Income TTM -82.1m / Total Stockholder Equity -273.2m)
RoCE = unknown (Ebit -52.4m / (Equity -273.2m + L.T.Debt 73.6m))
RoIC = -84.55% (NOPAT -52.4m / Invested Capital 62.0m)
WACC = 4.13% (E(153.7m)/V(498.7m) * Re(6.02%)) + (D(345.0m)/V(498.7m) * Rd(4.16%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 96.97 | Cagr: 4.71%
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -53.2m)
EPS Correlation: 5.77 | EPS CAGR: 6.44% | SUE: -0.30 | # QB: 0
Revenue Correlation: 21.66 | Revenue CAGR: -10.93% | SUE: N/A | # QB: None
Additional Sources for AMTX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle